News&lnfo
RecBio is a high-tech enterprise jointly founded by the former vaccine R & D expert team from the Chinese Center for Disease Control and Prevention (China CDC) and the senior vaccine industrialization team.
The company has established a leading domestic R & D and innovation platform for new adjuvants, genetic engineering, and immune evaluation.

20150707

  • Categories:企业里程碑
  • Author:
  • Origin:
  • Time of issue:2015-07-07
  • Views:0

(Summary description)On July 7, 2015, the application for clinical trial of recombinant bivalent HPV-16/18 vaccine (Hansenula polymorpha) was accepted.

20150707

(Summary description)On July 7, 2015, the application for clinical trial of recombinant bivalent HPV-16/18 vaccine (Hansenula polymorpha) was accepted.

  • Categories:企业里程碑
  • Author:
  • Origin:
  • Time of issue:2015-07-07
  • Views:0
Information

20150707

Scan the QR code to read on your phone

Previous: 20120609
Previous: 20120609
  • TOP   

Contact Us

底部联系方式

Time of issue:2022-03-29 08:59:20

Jiangsu Recbio Technology Co., Ltd.

Media Inquiry: media@recbio.cn

Investor Inquiry: ir@recbio.cn

 

Address: Vaccine Engineering Center, China Medical City, Taizhou

Copyright © 2020 Jiangsu Rec-Biotechnology Co., Ltd.  All rights reserved.      苏ICP备19043567号-1